Zemplar

Paricalcitol (Zemplar) is a vitamin D analog used to manage secondary hyperparathyroidism in adults undergoing hemodialysis. This overview covers its role in regulating calcium and phosphate balance. Ideal for patients seeking kidney-related vitamin D support.

Paricalcitol (Zemplar) is prescribed to reduce elevated parathyroid hormone levels in adults with chronic kidney disease undergoing hemodialysis. It helps regulate calcium and phosphate metabolism, supporting bone health. Patients often ask, 'What is paricalcitol used for?' to address secondary hyperparathyroidism. It is not a general vitamin D supplement.

Paricalcitol works by activating vitamin D receptors to lower parathyroid hormone production. Users may notice improved calcium balance over time. It does not provide immediate symptom relief but supports long-term metabolic balance. Effects vary by individual and require regular monitoring.

Paricalcitol should be handled with care, especially by those with high calcium or phosphate levels. Regular blood tests are recommended to monitor response and safety. Patients with vitamin D toxicity or hypersensitivity should avoid use. Always follow healthcare provider instructions for administration.

Paricalcitol may interact with other vitamin D supplements, calcium-based medications, or phosphate binders. Strong CYP3A inhibitors can increase paricalcitol levels, while enzyme inducers may reduce its effectiveness. Alcohol and certain antacids may also affect absorption. Consult a healthcare provider before combining medications.